CCXI Price Targets and Analyst Ratings NASDAQ:CCXI
CCXI Forecast. What You Should Know.
CCXI Historical Ratings and Targets
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.